Figure 4.
CB2R activation reduces neutrophil migration towards chemoattractant. (A) Bar graph represents the mean number of neutrophils from WT or CB2R-/- mice pre-treated with various concentrations of the CB2R agonist, RO6871304, that migrated to the lower chamber of a Boyden chamber setup when using CXCL2 (10−8 M) as a chemoattractant. Neutrophils were counted from 12 random microscopic fields of view per well. (B) Bar graph represents the mean number of neutrophils from WT mice pre-treated with various concentrations of the CB2R inverse agonist, RO6851228, or vehicle (0.01% DMSO) that migrated in the Boyden chamber setup. Data are presented as the mean neutrophil migration per microscopic field of view ± SD from at least three independent experiments conducted in triplicate each. One-way ANOVA with Dunnett; ** p < 0.01 compared to WT neutrophils + CXCL2 + vehicle.